title: Why is the mammary artery so special and what protects it from atherosclerosis?
abstract: The internal mammary artery (IMA) grafts have been associated with long-term patency and improved survival as compared to saphenous vein grafts (SVGs). Early failure of IMA is attributed to poor surgical technique and less with thrombosis. Similarly, bypass surgery especially with the use of IMA has also been shown to be superior at 1-year as well as over five years compared to percutaneous procedures, including the use of drug-eluting stents for the treatment of coronary artery disease. The superiority of IMAs over SVGs can be attributed to its striking resistance to the development of atherosclerosis. Structurally its endothelial layer shows fewer fenestrations, lower intercellular junction permeability, greater anti-thrombotic molecules such as heparin sulfate and tissue plasminogen activator, and higher endothelial nitric oxide production, which are some of the unique ways that make the IMA impervious to the transfer of lipoproteins, which are responsible for the development of atherosclerosis. A better comprehension of the molecular resistance to the generation of adhesion molecules that are involved in the transfer of inflammatory cells into the arterial wall that also induce smooth muscle cell proliferation is needed. This basic understanding is crucial to championing the use of IMA as the first line of defense for the treatment of coronary artery disease.
authors: CVPath Institute, Inc., Gaithersburg, MD, USA.
authors: Fumiyuki
authors: F
authors: Otsuka
authors: Kazuyuki
authors: K
authors: Yahagi
authors: Kenichi
authors: K
authors: Sakakura
authors: Renu
authors: R
authors: Virmani
keywords: Coronary artery disease; internal mammary artery (IMA); pathology; saphenous vein graft (SVG)
references: Ann Thorac Surg. 1976 Jun;21(6):504-7
references: 1275603
references: J Am Coll Cardiol. 1988 Feb;11(2):297-307
references: 2892871
references: Circ Cardiovasc Interv. 2013 Jun;6(3):269-76
references: 23716001
references: Ann Thorac Surg. 2012 Dec;94(6):1934-9
references: 22884597
references: Chest. 1985 Sep;88(3):341-8
references: 3875453
references: J Vasc Surg. 2004 Sep;40(3):529-35
references: 15337884
references: Ann Thorac Surg. 2004 Oct;78(4):1290-4; discussion 1290-4
references: 15464487
references: Cardiovasc Res. 1997 Jun;34(3):557-67
references: 9231039
references: Circulation. 1998 Mar 10;97(9):916-31
references: 9521341
references: N Engl J Med. 1984 Nov 22;311(21):1329-32
references: 6333635
references: Curr Opin Cardiol. 2005 Nov;20(6):521-4
references: 16234624
references: Am J Cardiol. 1985 Jan 1;55(1):65-71
references: 3871302
references: JACC Cardiovasc Interv. 2012 Jun;5(6):666-74
references: 22721663
references: N Engl J Med. 1996 Jan 25;334(4):263-5
references: 8532006
references: Heart Surg Forum. 2012 Apr;15(2):E61-8
references: 22543338
references: N Engl J Med. 2012 Dec 20;367(25):2375-84
references: 23121323
references: N Engl J Med. 1996 Jan 25;334(4):216-9
references: 8531997
references: N Engl J Med. 1996 Jul 25;335(4):217-25
references: 8657237
references: N Engl J Med. 1997 Jan 16;336(3):153-62
references: 8992351
references: Am Heart J. 1986 Jan;111(1):143-51
references: 2868643
references: Ann Thorac Surg. 2002 Apr;73(4):1341-5
references: 11996297
references: J Thorac Cardiovasc Surg. 2005 Apr;129(4):767-72
references: 15821642
references: Ann Thorac Surg. 2000 Oct;70(4):1338-44
references: 11081895
references: Am J Physiol Heart Circ Physiol. 2008 Jun;294(6):H2831-7
references: 18441195
references: Curr Opin Cardiol. 2011 Nov;26(6):508-17
references: 21934497
references: Circulation. 2004 Sep 14;110(11 Suppl 1):II27-35
references: 15364834
references: J Am Coll Cardiol. 2004 Dec 7;44(11):2149-56
references: 15582312
references: N Engl J Med. 2012 Apr 19;366(16):1467-76
references: 22452338
references: N Engl J Med. 1986 Jan 2;314(1):1-6
references: 3484393